Analyzing AdvanSix (ASIX) and Its Rivals

AdvanSix (NYSE: ASIX) is one of 47 publicly-traded companies in the “Specialty Chemicals” industry, but how does it weigh in compared to its rivals? We will compare AdvanSix to similar businesses based on the strength of its risk, earnings, dividends, profitability, analyst recommendations, valuation and institutional ownership.

Volatility & Risk

AdvanSix has a beta of 2.84, meaning that its share price is 184% more volatile than the S&P 500. Comparatively, AdvanSix’s rivals have a beta of 1.37, meaning that their average share price is 37% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current recommendations for AdvanSix and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AdvanSix 0 0 1 0 3.00
AdvanSix Competitors 172 1042 1315 24 2.47

AdvanSix currently has a consensus price target of $46.00, indicating a potential upside of 13.19%. As a group, “Specialty Chemicals” companies have a potential upside of 0.22%. Given AdvanSix’s stronger consensus rating and higher possible upside, equities analysts plainly believe AdvanSix is more favorable than its rivals.

Profitability

This table compares AdvanSix and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
AdvanSix 3.64% 20.30% 5.64%
AdvanSix Competitors -655.93% -4.23% 0.37%

Insider and Institutional Ownership

71.4% of AdvanSix shares are owned by institutional investors. Comparatively, 65.3% of shares of all “Specialty Chemicals” companies are owned by institutional investors. 2.7% of AdvanSix shares are owned by insiders. Comparatively, 7.4% of shares of all “Specialty Chemicals” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares AdvanSix and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
AdvanSix $1.19 billion $34.14 million 25.72
AdvanSix Competitors $1.91 billion $115.75 million 229.65

AdvanSix’s rivals have higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

AdvanSix beats its rivals on 8 of the 13 factors compared.

AdvanSix Company Profile

AdvanSix Inc. is an integrated manufacturer of Nylon 6. The Company also sells a variety of other products, all of which are produced as part of the Nylon 6 resin manufacturing process primarily, including caprolactam, ammonium sulfate fertilizers and other chemical intermediates. The Company operates primarily through its integrated manufacturing sites located in Frankford, Pennsylvania, Hopewell, Virginia, and Chesterfield, Virginia. The Company offers ammonium sulfate, which is used by customers as a nitrogen-based fertilizer. It produces ammonium sulfate fertilizer as part of its manufacturing process. The Company manufactures ammonium sulfate fertilizers including Sulf-N and Sulf-N 26. The Company provides AdvanSix Aegis nylon resins and Aegis barrier nylon resins. Its nylon resins are a preferred choice in food, liquid, and consumer packaging along with mono/multifilament products, carpet fibers, automotive compounding and more. It offers Capran biaxially oriented nylon films.

Receive News & Ratings for AdvanSix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdvanSix and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply